Giuseppe Lippi/LinkedIn
Mar 14, 2026, 12:59
Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Happy to share our new article on ‘Heparin Anticoagulant Therapy and Its Monitoring’.”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules
See more in the gallery.
Other posts featuring Giuseppe Lippi on Hemostasis Today.
-
Apr 25, 2026, 11:44Ruiming Li: Why the COMBO Plus form is a Masterclass in Vascular Repair
-
Apr 25, 2026, 11:19Nathan Connell: Bleeding Risk Is Not Limited to Delivery
-
Apr 25, 2026, 11:14Rashad Mohamed: What Does ‘Capping’ Mean in Anticoagulant Dosing?
-
Apr 25, 2026, 11:07Anne de Vaan: The Results of the PRIDES Study Are Now Available
-
Apr 25, 2026, 10:50Flora Peyvandi: Proteomic Insights of Relapse Risk in Thrombotic Thrombocytopenic Purpura
-
Apr 25, 2026, 10:40Kalyan Roy: Effect of Irradiation on Red Blood Cells
-
Apr 25, 2026, 10:38David Sinclair: How are High Omega-3 Levels Linked to Low Mortality Risk
-
Apr 25, 2026, 10:26Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
-
Apr 25, 2026, 10:05Lutz Knabe: One Child’s Journey from Pain to Hope Beyond Severe Bleeding Disorder